DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity

脂肪变性 内分泌学 内科学 肝细胞 胰岛素抵抗 脂肪肝 生物 医学 癌症研究 糖尿病 体外 遗传学 疾病
作者
Lanfeng Xie,Pi‐Xiao Wang,Peng Zhang,Xiao‐Jing Zhang,Guang‐Nian Zhao,Aibing Wang,Junhong Guo,Xueyong Zhu,Qin Zhang,Hongliang Li
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:65 (1): 113-124 被引量:78
标识
DOI:10.1016/j.jhep.2016.03.008
摘要

Background & Aims Dickkopf-3 (DKK3), a protein belonging to the DKK family, has been extensively investigated in the context of cancer, including liver cancer. However, the role of DKK3 in hepatic steatosis and related metabolic disorders remains largely unexplored. Methods We detected the expression of DKK3 in the fatty livers of NAFLD patients and of obese mice and investigated the function of DKK3 in hepatic steatosis and related metabolic disorders by using hepatocyte-specific DKK3 deficiency or overexpression obese mice induced by high fat diet (HFD) or genetic defect (ob/ob). The molecular mechanisms underlying DKK3-regulated hepatic steatosis were further explored and verified in mice. Results DKK3 expression was significantly decreased in the livers of NAFLD patients and of obese mice as well as in cultured hepatocytes stimulated with palmitate. Further investigation indicated that specific overexpression of DKK3 in hepatocytes enhanced insulin sensitivity and glucose tolerance, reduced the inflammatory response, and ameliorated the imbalance of lipid metabolism in response to HFD or genetic defects. In contrast, DKK3 deficiency in hepatocytes led to an almost complete reversal of these pathologies. Mechanistically, DKK3 combined with Apoptosis signal-regulating kinase 1 (ASK1) under palmitate stimulation, and thus inhibited the activation of the downstream P38/JNK pathway. Importantly, dominant-negative ASK1 blocked the accelerated effects of DKK3 deficiency, while the constitutively active form of ASK1 overcame the inhibitory effects of DKK3 overexpression on HFD-induced metabolic disorders in vivo. Conclusion DKK3 functions as a negative regulator of insulin resistance, hepatic steatosis, and associated inflammatory responses, which depends on its inhibitory regulation of ASK1 activity. Lay summary DKK3 expression is decreased in the non-alcoholic fatty liver of humans and mice. Adding DKK3 expression alleviates fatty liver in mice by inhibiting ASK1 activity. Dickkopf-3 (DKK3), a protein belonging to the DKK family, has been extensively investigated in the context of cancer, including liver cancer. However, the role of DKK3 in hepatic steatosis and related metabolic disorders remains largely unexplored. We detected the expression of DKK3 in the fatty livers of NAFLD patients and of obese mice and investigated the function of DKK3 in hepatic steatosis and related metabolic disorders by using hepatocyte-specific DKK3 deficiency or overexpression obese mice induced by high fat diet (HFD) or genetic defect (ob/ob). The molecular mechanisms underlying DKK3-regulated hepatic steatosis were further explored and verified in mice. DKK3 expression was significantly decreased in the livers of NAFLD patients and of obese mice as well as in cultured hepatocytes stimulated with palmitate. Further investigation indicated that specific overexpression of DKK3 in hepatocytes enhanced insulin sensitivity and glucose tolerance, reduced the inflammatory response, and ameliorated the imbalance of lipid metabolism in response to HFD or genetic defects. In contrast, DKK3 deficiency in hepatocytes led to an almost complete reversal of these pathologies. Mechanistically, DKK3 combined with Apoptosis signal-regulating kinase 1 (ASK1) under palmitate stimulation, and thus inhibited the activation of the downstream P38/JNK pathway. Importantly, dominant-negative ASK1 blocked the accelerated effects of DKK3 deficiency, while the constitutively active form of ASK1 overcame the inhibitory effects of DKK3 overexpression on HFD-induced metabolic disorders in vivo. DKK3 functions as a negative regulator of insulin resistance, hepatic steatosis, and associated inflammatory responses, which depends on its inhibitory regulation of ASK1 activity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Yob完成签到,获得积分10
刚刚
乐乐的应助被zyy采纳,获得30
1秒前
规划计划完成签到 ,获得积分10
1秒前
科研通AI6.2的应助被tjl采纳,获得10
2秒前
邱燈完成签到,获得积分10
3秒前
SciGPT的应助被外向的大狮子采纳,获得10
4秒前
4秒前
天天快乐的应助被6666采纳,获得10
4秒前
伶俐绿柏完成签到,获得积分10
5秒前
5秒前
传奇3的应助被JF123_采纳,获得10
5秒前
Owen的应助被yansiyi采纳,获得20
6秒前
eerrtt完成签到,获得积分10
7秒前
7秒前
7秒前
松下完成签到,获得积分10
7秒前
8秒前
打打的应助被廖翰彬采纳,获得10
8秒前
8秒前
Qiiiyoung完成签到,获得积分10
8秒前
张远幸发布了新的文献求助10
9秒前
9秒前
9秒前
peng完成签到,获得积分10
9秒前
10秒前
缺粥发布了新的文献求助10
11秒前
华仔的应助被吴呜呜采纳,获得10
12秒前
所所的应助被1111采纳,获得10
12秒前
Micheallee完成签到,获得积分10
12秒前
Hello的应助被老汉憨憨采纳,获得10
13秒前
科研通AI6.4的应助被dde采纳,获得30
13秒前
14秒前
个性天晴完成签到 ,获得积分10
15秒前
15秒前
鲤鱼鑫磊发布了新的文献求助10
15秒前
丘比特的应助被zyy采纳,获得30
15秒前
111发布了新的文献求助10
15秒前
16秒前
科研通AI65的应助被西北采纳,获得10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820